Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

J&J wins partial appeal against U.K.’s cost-effectiveness watchdog

admin by admin
September 10, 2022
in Pharmaceutical



In an unusual turn of events, an appeals panel ruled that the U.K.’s cost effectiveness watchdog agency acted unfairly and exceeded its authority by failing to thoroughly explain why it declined to recommend a Johnson & Johnson medicine called Spravato for combating treatment-resistant depression.

Specifically, the panel determined that the National Institute for Health and Care Excellence did not thoroughly convey its views on how uncertainties in the evidence that are “inherent to clinical trials in mental health were taken into account in its decision making.” The agency was directed to now “take all reasonable steps” to explain its position.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED





Source link

Previous Post

Health Bulletin 9/September/2022

Next Post

Roflumilast Foam Effectively Eases Seborrheic Dermatitis

Next Post

Roflumilast Foam Effectively Eases Seborrheic Dermatitis

Recommended

Keytruda Approved as Adjuvant Treatment for Stage IB, II, or IIIA NSCLC

January 30, 2023

Few HIV Patients Treated for Hep C Given Contraindicated HIV Drugs

August 22, 2022

Don't miss it

Pharmaceutical

ALS Association battles its chapters over money, priorities

February 3, 2023
Medicines & Healthy Lifestyle

Surgery and Prescriptions Now Advised for Obese Children?

February 3, 2023
Medicines & Healthy Lifestyle

Jesduvroq Approved for Anemia of CKD in Patients on Dialysis

February 3, 2023
Medicines & Healthy Lifestyle

Prescribing Medication Dosage According To DNA Profile Lowers Side Effects By 30%: Study

February 3, 2023
News

Longer Diabetes Duration Links With Increased Heart Failure

February 3, 2023
Pharmaceutical

Health Bulletin 3/ February/ 2023

February 3, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.